KDA Group (TSXV:KDA) Ending Cash Position: C$0.24 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is KDA Group Ending Cash Position?

KDA Group TSXV:KDA Ending Cash Position is C$0.24 Mil as of Apr. 2026. The stock has 3 warning signs investors should review.

KDA Group's Ending Cash Position for the quarter that ended in Apr. 2026 was C$0.24 Mil.

KDA Group's quarterly Ending Cash Position increased from Oct. 2025 (C$0.06 Mil) to Jan. 2026 (C$0.42 Mil) but then declined from Jan. 2026 (C$0.42 Mil) to Apr. 2026 (C$0.24 Mil).

KDA Group's annual Ending Cash Position declined from Jul. 2023 (C$4.63 Mil) to Jul. 2024 (C$1.65 Mil) and declined from Jul. 2024 (C$1.65 Mil) to Jul. 2025 (C$0.13 Mil).

KDA Group Ending Cash Position Related Terms

KDA Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for KDA Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDA Group Ending Cash Position Chart

KDA Group Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.74 4.63 1.65 0.13

KDA Group Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.13 0.06 0.42 0.24

KDA Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

KDA Group's Ending Cash Position for the fiscal year that ended in Jul. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.647+-1.513
=0.13

KDA Group's Ending Cash Position for the quarter that ended in Apr. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.418+-0.176
=0.24

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of C$0.24 Mil mean?
KDA Group (TSXV:KDA) has a Ending Cash Position of C$0.24 Mil as of Apr. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on KDA Group and its competitors.
Is KDA Group's Ending Cash Position too high?
KDA Group's current Ending Cash Position is C$0.24 Mil.
How does KDA Group's Ending Cash Position compare to VEEV and BTSG?
KDA Group's Ending Cash Position of C$0.24 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on KDA Group and its competitors. KDA Group's current Ending Cash Position is C$0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDA Group stock overvalued right now?
KDA Group (TSXV:KDA) has a current Ending Cash Position of C$0.24 Mil. The current Ending Cash Position is C$0.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For KDA Group (TSXV:KDA), the current Ending Cash Position is C$0.24 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

KDA Group Business Description

Other Exchanges KDAGF:USAO1M:Germany
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.